AzTrials
AzTrials

Psychosocial FunctioningNCT01651091

Effects of Meditation Awareness Training on Psychosocial Functioning in Prison Participants

A study testing Meditation Awareness Training and Treatment as usual in people with Psychosocial Functioning, run by Nottingham Trent University at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effects of an eight-week long group-based secular intervention known as Meditation Awareness Training (MAT) on psychosocial functioning in prison participants. Read more about this study

Who is it for?
Ages 18 to 65 years, men only
Conditions the study is for
Psychosocial Functioning
What is being tested?
Meditation Awareness Training and Treatment as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 siteUnited Kingdom
Study dates
Mar 2013to Nov 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Men only
  • Adult, Older adult

Who may be able to join

  • Adult male (aged 18 to 65)
  • English speaking
  • Intact cognition(mini-mental status exam ≥23)
  • Incarceration for an act of instrumental violence
  • Evidence of self-harming and/or suicidal ideations and/or substance-use during the 12 months prior to the study.

Who cannot join

  • current participation in a program of structured psychotherapy or counselling
  • any prior formal meditation training
  • psychopharmacology commenced or dosage changed one-month prior to intervention (stable medication permitted)

Trial locations and contacts

1 site in 1 country.

Edo Shonin contact

edo.shonin@ntu.ac.uk

United Kingdom1 site
  • Nottingham Trent University

    Nottingham, NG1 4BU

    Edo Shonin, edo.shonin@ntu.ac.uk

Other trials in United Kingdom

About this study

Official title: Effects of Meditation Awareness Training on Psychosocial Functioning in Prison Participants: A Randomized Controlled Trial

The purpose of this study is to investigate the effects of an eight-week long group-based secular intervention known as Meditation Awareness Training (MAT) on psychosocial functioning in prison participants.

Read the detailed description

In Western practitioner settings, Buddhist principles are increasingly being used in the treatment of a wide range of mental health issues. However, there is a dearth of high quality research examining the effects of Buddhist-derived interventions (BDIs) on mental health in forensic settings. The purpose of this study is to assess the salutary effects and acceptability of a secularised group-based eight-week BDI known as Meditation Awareness Training (MAT) against relevant predictors of adaptive psychosocial functioning and mental health in violent offenders. A randomized controlled trial (RCT) design will be employed structured with reference to CONSORT (Consolidated Standards of Reporting Trials) 2010 guidelines. English speaking adult males (aged 18-65 years) serving indeterminate prison sentences for offences of instrumental violence at a category B prison will be invited to receive MAT on a voluntary basis. Computer-generated numbers will be used to randomly allocate prison participants (n=102 - based on statistical power calculations) to either an intervention or 'treatment as usual' (TAU) control condition. Measures will be taken pre- and post-intervention and at three-month follow-up to assess maintenance effects.

Being tested
Meditation Awareness Training, Treatment as usual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01651091
Study groupRoleWhat they receive
Meditation Awareness TrainingExperimentalNot described
Receives: Other: Meditation Awareness Training
Treatment as UsualActive comparatorNot described
Receives: Other: Treatment as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Risk of Reoffending

Secondary outcomes (5)
  1. Anger levels

  2. Self-esteem

  3. Substance-use locus of control

  4. Self-harming

  5. Affective mood states

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2012 (estimated)
  2. Study startMar 2013
  3. Primary completionNov 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
102 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01651091
Sponsor's protocol ID
MAT-30072012-T
Status last verified
Aug 2012
First submitted
24 Jul 2012
Last updated
7 Aug 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Meditation Awareness Training and Treatment as usual in people with Psychosocial Functioning, run by Nottingham Trent University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Edo Shonin (edo.shonin@ntu.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Risk of Reoffending. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in